Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.

Citation

Grimur Høgnason Mohr, Carlo Alberto Barcella, Klara Coello, Lone Baandrup, Filip Krag Knop. Dyslipidaemia in patients with mental illness]. Ugeskrift for laeger. 2022 Mar 07;184(10)

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 35315756

View Full Text